Pi Network’s Token Plunges Even as Second Migrations Roll Out
Pi Network’s PI token slid about 10% in the last 24 hours, trading near $0.177 and hitting a two-week low as the proj...
When To Diversify Beyond Indices
When To Diversify Beyond Indices offers criteria and steps to broaden exposure beyond benchmarks, reducing risk and potentially improving returns.
20,072 articlesCrowdStrike Hitches Ride Nebius: Should You Buy Now?
CrowdStrike forms a strategic tie-up with Nebius Group to integrate Falcon security into Nebius AI Cloud, while repor...
Healthequity (HQY) 2026 Earnings Outlook and Trends
Investors are eyeing healthequity (hqy) 2026 earnings as HealthEquity navigates an evolving HSA landscape. This guide...
Markwayne Mullin Called Rand: DHS Hearing Sparks Debate
A tense confirmation hearing put the Department of Homeland Security funding in the spotlight as Markwayne Mullin cla...
North Korea-Linked Hackers Suspected in Crypto Breach
Bitrefill disclosed a March 1 cyberattack that drained funds and triggered a broader security review. Early investiga...
SoundHound Sinks What NVIDIA’s Bet Says About AI Market
SoundHound AI’s stock fell 6% to dip below $7 after the CFO resigns, with NVIDIA expanding edge AI ties. The move hig...
Tower Semiconductor Rallied Over AI Push This Week
A wave of enthusiasm for AI infrastructure helped Tower Semiconductor leap higher this week. Investors spotlighted si...
SanDisk Drops 5%: AI Breakout or Speculative Bubble?
SanDisk moved down about 5% after reporting strong Q4 results, fueling a sharp debate on whether the AI-led rally in ...
Shares Trade Below HAPAG-LLOYD’S Offer Amid ZIM Hurdles
ZIM shares hover near $27.54, well under Hapag-Lloyd’s $35 cash proposal. The discount reflects regulatory risk aroun...
Nvidia Trades Times Forward: Is It a Real Value Play Today?
Nvidia has built an AI powerhouse, but its stock sits at a valuation that invites scrutiny. This guide breaks down wh...
Chevron Says Prices Still Too Low, Hormuz Risk Not Priced In
Chevron’s CEO warned that oil prices are still too low given the ongoing Strait of Hormuz disruption. Markets have no...
Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status